2001
DOI: 10.1067/mpd.2001.114017
|View full text |Cite
|
Sign up to set email alerts
|

Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
79
0
5

Year Published

2004
2004
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(85 citation statements)
references
References 18 publications
1
79
0
5
Order By: Relevance
“…Numerous studies come in agreement with our results and concluded that the reduction in CAT-score detects early health status improvement and chest wall vibration reduces dyspnea in COPD patients. 4,6,12,23 Our results also coincide with pilot study carried out by Chakravorty et al whom reported that patients with AECOPD and mucus hypersecretion are at increased risk of declining lung function, tolerated the HFCWO treatment well, leading to improvement in CAT-score and quality of life and reduced symptoms. 7 Moreover; our result is consistent with Mahajan et al, who stated that HFCWO is well tolerated in adults hospitalized for AECOPD or acute asthma and significantly improves dyspnea, also reported that patient with AECOPD use fewer antibiotics, due to fewer respiratory infections with less hospitalization.…”
Section: Discussionsupporting
confidence: 78%
See 2 more Smart Citations
“…Numerous studies come in agreement with our results and concluded that the reduction in CAT-score detects early health status improvement and chest wall vibration reduces dyspnea in COPD patients. 4,6,12,23 Our results also coincide with pilot study carried out by Chakravorty et al whom reported that patients with AECOPD and mucus hypersecretion are at increased risk of declining lung function, tolerated the HFCWO treatment well, leading to improvement in CAT-score and quality of life and reduced symptoms. 7 Moreover; our result is consistent with Mahajan et al, who stated that HFCWO is well tolerated in adults hospitalized for AECOPD or acute asthma and significantly improves dyspnea, also reported that patient with AECOPD use fewer antibiotics, due to fewer respiratory infections with less hospitalization.…”
Section: Discussionsupporting
confidence: 78%
“…27 Other two authors reported that the Flutter as an oscillating PEP device enhances movement of secretions from the peripheral to the central airways lumen, improving lung function and oxygenation. 5,6 Additionally, Zakerimoghadam et al, mentioned that chest physiotherapy whatever its types enhance MCC, increase ventilation and improve blood gases. 3 The improved spirometric-indices reported among our patients in HFCWO or Flutter with no improvement in control group (Table 3), was similar to the results reported by Nicolini et al, who concluded that, there was significant improvement in pulmonary function tests (FEV1 or FVC) in CPT and HFCWO treated patients in comparison to control group.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The proportions of the different airway clearance techniques recorded for people with CF in the UK are broadly comparable with Canada, except for a bias towards PEP over oscillating PEP in Canada. This difference may be explained by several Canadian studies which found that PEP therapy is more effective than flutter devices (a form of oscillating PEP) [28] and postural drainage [29].…”
Section: Variation By Countrymentioning
confidence: 84%
“…A study comparing autogenous drainage with Flutter® reported no differences in the amount of sputum produced by application of either of the two methods [4]; however, the Flutter® device was reported to be more effective in reducing viscoelasticity of the secretion. The positive expiratory pres-DOI: 10.5152/TurkThoracJ.2018.17050 Bilge Üzmezoğlu 1 sure was shown to be more effective than Flutter® in terms of preserving pulmonary function, hospital admissions, and antibiotic use in patients, who were followed up for 1 year [5]. Daily use of the Flutter® device at home was as effective as ACBT in patients with non-CF bronchiectasis, and it leads to higher levels of adherence by patients [3].…”
Section: Introductionmentioning
confidence: 99%